EBE-A22
CAS No. 229476-53-3
EBE-A22( EBE-A22 | EBE A22 | EBEA22 )
Catalog No. M17448 CAS No. 229476-53-3
EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 32 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 95 | In Stock |
|
| 50MG | 142 | In Stock |
|
| 100MG | 214 | In Stock |
|
| 200MG | 300 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEBE-A22
-
NoteResearch use only, not for human use.
-
Brief DescriptionEBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
-
DescriptionEBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintains a high cytotoxic profile. EBE-A22 binds to DNA and behave as typical intercalating agents. EBE-A22 unwinds supercoiled plasmid, stabilizes duplex DNA against heat denaturation, and produces negative CD and ELD signals, as expected for an intercalating agent. EBE-A22, but not PD153035, interacts preferentially with GC-rich sequences and discriminates against homooligomeric runs of A and T which are often cut more readily by the enzyme in the presence of the drug compared to the control.
-
In Vitro——
-
In Vivo——
-
SynonymsEBE-A22 | EBE A22 | EBEA22
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorEGFR/ErbB1
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number229476-53-3
-
Formula Weight374.23
-
Molecular FormulaC17H16BrN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 133.61 mM; H2O : < 0.1 mg/mL
-
SMILESCN(c1cc(ccc1)Br)c1ncnc2cc(c(cc12)OC)OC
-
Chemical NameN-(3-bromophenyl)-6,7-dimethoxy-N-methylquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goossens JF, et al. DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogue. Biochemistry. 2001 Apr 17;40(15):4663-71.
molnova catalog
related products
-
Vofatamab
Vofatamab (B-701) is a fully human monoclonal antibody targeting FGFR3. Vofatamab has potential anticancer and antitumor activity and is often used in combination with other compounds to treat cancer.
-
AG473
AG473 is an inhibitor of EGFR in human A431 cells.Expressed the Ag473 lipoprotein from Neisseria meningitides, flagellin FlaB from Vibrio vulnificus and heat shock protein 70 from Mycobacterium tuberculosis (mHsp70) in Escherichia coli as single proteins and fusion proteins with VP2 protein of infectious bursal disease virus (IBDV).?
-
Sunitinib Malate
Potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor.
Cart
sales@molnova.com